TapImmune, Inc. (NASDAQ: TPIV) is “One to Watch”

From The QualityStocks Daily Blog for Micro-cap and Small-Cap Companies
March 14, 2017 - 8:54am
TapImmune, Inc. (NASDAQ: TPIV) is leading the field of oncology with its next-generation T-cell vaccines and novel immunotherapy platforms. By fully leveraging the scope of its technology and through collaborative partnerships and license agreements, the company aims to maximize its value and growth potential. Most cancer patients die from metastatic disease, which is when the […]


Continue reading this article »